We are live on ! Find out more

7 hedge funds and large institutions have $50M invested in BiomX in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more capital invested

Capital invested by funds: $19.1M → $50M (+$30.9M)

0.01% more ownership

Funds ownership: 0.11%0.12% (+0.01%)

46% less funds holding

Funds holding: 137 (-6)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
-6
Holders Change %
-46.15%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
Reduced
1
Closed
12
Calls
$77K
Puts
Net Calls
+$77K
Net Calls Change
+$77K

PHGE Hedge Fund Activity: Q4 2019 in Review

7 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q4 2019, worth a combined $50M — up 162% from $19.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of PHGE and 6 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $21M. The largest seller was K2 Principal Fund, cutting an estimated $3.35M.

  • 7 institutional investors held BiomX (PHGE) as of Q4 2019, down from 13 in Q3 2019.
  • Funds reported $50M of BiomX stock for Q4 2019, up 162% quarter-over-quarter.
  • 6 funds opened new BiomX positions in Q4 2019 and 12 closed out, a net change of -6 holders.
  • The largest BiomX buyer in Q4 2019 was OrbiMed, an estimated $21M added.
  • The largest BiomX seller in Q4 2019 was K2 Principal Fund, an estimated $3.35M sold.

Based on aggregated 13F filings for Q4 2019.